Reconstituted Peptide Stability and Temperature: What the Published Literature Reports

Post-reconstitution stability is an analytical question, and the published literature approaches it mainly through chromatographic, spectroscopic, and activity-based assays on solutions held at defined temperatures. In one laboratory study, the peptide hormone product sincalide was reconstituted in sterile water and held at room temperature and under refrigeration (n = 4 per condition), with samples quantified by a validated high-performance liquid chromatography method; the authors reported little to no chemical degradation of the active ingredient over more than 8 days under either condition, alongside a trend toward cyclic fluctuation in measured concentration [1]. The same authors noted that their in vitro chemical data did not address microbial growth, and stated that microbiological testing over the same storage duration would be required before any extended-use conclusions were drawn [1]. Other work has combined chemical and functional read-outs. A laboratory study of a commercially available recombinant glucagon formulation examined reconstituted material incubated in subcutaneous infusion pump systems at 32 °C, using liquid chromatography with tandem mass spectrometry for degradation, intrinsic tryptophan fluorescence for fibrillation, and a cell-based protein kinase A fluorescent bioassay for activity; the peptide was reported as 93.0% ± 7.0% intact after 24 h and 83.04% ± 6.0% after 48 h relative to freshly reconstituted samples, with no significant shifts in fluorescence peak wavelength or EC50 under the movement and air-bubble conditions tested [2]. Structural characterisation of a reconstituted lyophilised clinical formulation of the double-mutant Escherichia coli heat-labile toxin adjuvant (dmLT) found a heterogeneous mixture of intact holotoxin (approximately 75%) and free B5 subunit (approximately 25%) by analytical ultracentrifugation and hydrophobic interaction chromatography, and forced-degradation studies with liquid chromatography–mass spectrometry peptide mapping identified specific asparagine deamidation and methionine oxidation sites [3]. In that in vitro work, multiple biophysical measurements indicated greatest stability between pH 6.5 and 7.5 and at temperatures at or below 50 °C, while shaking stress produced soluble aggregates and particles [3]. A narrative review of oncological medicines similarly catalogued oxidation, deamidation, acylation, and photo-induced reactions as prominent chemical degradation mechanisms in peptides, monoclonal antibodies, and antibody-drug conjugates, and described temperature fluctuation as a driver of physical instability and aggregation, with post-reconstitution stability framed as dependent on cold-chain control and conditioning [4]. Temperature-dependent loss of measurable activity has also been reported for non-peptide and glycopeptide reconstituted solutions, which illustrates how storage temperature is operationalised experimentally. Ceftazidime and vancomycin were reconstituted in balanced salt solution at 50 mg/mL and stored at 4 °C and 24 °C with and without light exposure; in vitro minimum bactericidal concentration testing showed that ceftazidime potency against Pseudomonas aeruginosa declined significantly from day 3 at 24 °C and from day 7 at 4 °C, was unaffected by light, and that loss of potency coincided with visual and olfactory signs of degradation, whereas vancomycin potency against Staphylococcus aureus remained stable across 4 weeks at either temperature [5]. Several studies address the drying and reconstitution steps themselves rather than solution storage. In an in vitro formulation study, human aminopeptidase B lost most activity on lyophilisation alone (6.4% retention), while co-lyophilisation with its substrate avizafone plus trehalose retained 71% of activity, and avizafone or trehalose alone retained 60% and 56%; lyophilizates of the substrate-plus-trehalose formulation showed negligible activity reduction after a 6-month accelerated stability study [6]. Work on nanoliposomes loaded with Arthrospira-derived peptide fractions reported, in vitro, that chitosan coating at 0.4% was associated with greater retention of particle size, encapsulation efficiency, and measured activity across temperature, freeze–thaw, and spray-drying stresses, and that coated freeze-dried vesicles retained physical characteristics after reconstitution [7]. An earlier in vitro study of cyclosporine-loaded poly-caprolactone nanoparticles found encapsulated drug content and particle size unchanged for at least 3 months at 8 °C and 25 °C, aggregate formation by 4 months, and that reconstituted freeze-dried preparations showed increased mean size unless glucose or trehalose was present above 10% [8]. In the development of an intravenous everolimus nanoparticle formulation, laboratory stability testing indicated the reconstituted product remained within specification for at least one month at 5 °C and for at least 24 h at room temperature in use, with manufacturing conducted under amber light to limit photodegradation [9]. Oil-based insulin reverse-micelle formulations prepared by freeze-drying and reconstitution with an oil phase were reported stable at room temperature for up to 12 months with no detected degradation products, in a study whose efficacy arm was conducted in diabetic rats and non-diabetic rabbits [10]. Mechanistic studies on intrinsic thermal stability provide the structural context for these observations. In semisynthetic ribonuclease S reconstituted from S-protein plus synthetic S-peptide analogues, in vitro measurements showed that peptide analogues with enhanced helix formation bound S-protein more tightly and raised the melting temperature of the reconstituted enzyme, with the largest increment being 6 °C [11]. Reconstitution of myristoylated versus non-myristoylated calcineurin B with recombinant calcineurin A showed no effect of acylation on catalytic activity or Ca2+ binding, but an approximately 10 °C increase in thermal half-life for the myristoylated form in vitro [12]. In vitro reconstitution of lasso peptide biosynthesis showed that fuscanodin, despite the thermal and chaotropic resistance often attributed to the lasso class, underwent a conformational change consistent with unthreading in organic solvents at room temperature [13]. Reconstituted Escherichia coli translation experiments found that premature termination arising from acidic-residue-enriched nascent peptides was itself temperature dependent [14], while a reconstituted three-protein cyanobacterial oscillator retained a period insensitive to environmental conditions across more than 20 KaiC mutants in vitro and in vivo in cyanobacteria [15]. Together these reports indicate that temperature effects on reconstituted material are read out differently depending on whether the assay measures chemical integrity [1][2][3], functional activity [5][6][12], or physical state [3][7][8].